(VIANEWS) – Shares of Alnylam Pharmaceuticals (NASDAQ Composite: ALNY) fell by a staggering 15.18% to $162.14 at 11:35 EST on Tuesday, following the last session’s upward trend. NASDAQ Composite is jumping 1.39% to $15,448.12, after three consecutive sessions in a row of gains. This seems, up to now, an all-around bullish trend exchanging session today.

Alnylam Pharmaceuticals’s last close was $166.36, 21.53% below its 52-week high of $212.00.


Today’s last reported volume for Alnylam Pharmaceuticals is 2766395 which is 348.8% above its average volume of 616393.

Alnylam Pharmaceuticals’s Sales

Alnylam Pharmaceuticals’s sales growth is 74.6% for the present quarter and 46.7% for the next. The company’s growth estimates for the ongoing quarter and the next is 28% and 23.9%, respectively.

Alnylam Pharmaceuticals’s Revenue

Year-on-year quarterly revenue growth grew by 112.1%, now sitting on 687.53M for the twelve trailing months.


Alnylam Pharmaceuticals’s last week, last month’s, and last quarter’s current volatility was a negative 7.65%, a negative 1.05%, and a positive 2.07%, respectively.

Alnylam Pharmaceuticals’s current volatility rank, which measures how volatile a financial asset is (variation between the lowest and highest value in a period), was 7.65% (last week), 2.12% (last month), and 2.07% (last quarter), respectively.

Stock Price Classification

According to the stochastic oscillator, a useful indicator of overbought and oversold conditions,

Alnylam Pharmaceuticals’s stock is considered to be overbought (>=80).

Alnylam Pharmaceuticals’s Stock Yearly Top and Bottom Value

Alnylam Pharmaceuticals’s stock is valued at $162.14 at 11:35 EST, way below its 52-week high of $212.00 and way above its 52-week low of $120.83.

Alnylam Pharmaceuticals’s Moving Average

Alnylam Pharmaceuticals’s worth is way below its 50-day moving average of $192.23 and under its 200-day moving average of $173.76.

More news about Alnylam Pharmaceuticals (ALNY).


Please enter your comment!
Please enter your name here